Search
Menu
Hamamatsu Corp. - Earth Innovations LB 2/24

Leica Microsystems, CMED Collaborate on FISH Kits

Facebook X LinkedIn Email
BEIJING & WETZLAR, Germany, Aug. 12, 2011 — In vitro diagnostic company China Medical Technologies Inc. (CMED) and Leica Biosystems, a division of Leica Microsystems, have established a sales, research and development collaboration to develop and market FISH kits for the Leica Bond system, an automated staining platform. The two companies will develop automated solutions for tissue sample tests on HER-2, EGFR and TOP2A genes, all three of which play a role in targeted drug therapy for breast, lung and stomach cancer patients. Both parties have agreed to work together on additional FISH applications during the term,...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: August 2011
    Asia-Pacificautomated FISH kitsBiophotonicsbreast cancer drug therapyBusinesscancer therapy drugsChinaChina Medical Technologies Inc.CMEDcytologyEGFR geneEuropeFISH kitsGermanyHER-2 genehistopathologyImagingin vitro diagnosticsLeica BiosystemsLeica BONDLeica Microsystemslung cancer drug therapymicroscopesMicroscopyprenatal applicationsstaining platformstomach cancer drug therapytissue sample testsTOP2A gene

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.